Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy-Reference-Cited by-同舟云学术

Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy

Published:2024-09 Issue: Volume: Page:
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Hegde Sheila M.^ORCID,Claggett Brian L.,Wang Xiaowen,Jering Karola,Prasad Narayana,Roshanali Farideh,Masri Ahmad^ORCID,Nassif Michael E.,Barriales-Villa Roberto,Abraham Theodore P.,Cardim Nuno,Coats Caroline J.,Kramer Christopher M.,Maron Martin S.,Michels Michelle,Olivotto Iacopo,Saberi Sara,Jacoby Daniel L.,Heitner Stephen B.,Kupfer Stuart,Meng Lisa,Wohltman Amy,Malik Fady I.,Solomon Scott D.

Funder

Cytokinetics Inc

Publisher

Elsevier BV

Reference53 articles.

1. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines;Ommen;J Am Coll Cardiol,2024

2. Hypertrophic cardiomyopathy: clinical update;Geske;JACC Heart Fail,2018

3. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy;Maron;N Engl J Med,2003

4. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy;Ommen;J Am Coll Cardiol,2005

5. Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy: An Update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography